Autoantibodies as potential biomarkers of immune-related adverse events in patients with advanced cutaneous melanoma treated with immune checkpoint inhibitors.

Aesha Gandhi; John Taylor; Michael Morici; Anna Reid; Tarek Meniawy; Muhammad Adnan Khattak; Elin Gray; Michael Millward; Pauline Zaenker

Autoantibodies as potential biomarkers of immune-related adverse events in patients with advanced cutaneous melanoma treated with immune checkpoint inhibitors.

Aesha Gandhi, John Taylor, Michael Morici, Anna Reid, Tarek Meniawy, Muhammad Adnan Khattak, Elin Gray, Michael Millward, Pauline Zaenker

Internal Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	40
Issue number	16
Publication status	Published - 1 Jun 2022

Cite this

@article{3514aeb64bb84bc88f78dd6bf1a1bee1,

title = "Autoantibodies as potential biomarkers of immune-related adverse events in patients with advanced cutaneous melanoma treated with immune checkpoint inhibitors.",

author = "Aesha Gandhi and John Taylor and Michael Morici and Anna Reid and Tarek Meniawy and Khattak, {Muhammad Adnan} and Elin Gray and Michael Millward and Pauline Zaenker",

year = "2022",

month = jun,

day = "1",

language = "English",

volume = "40",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "16",

}

TY - JOUR

T1 - Autoantibodies as potential biomarkers of immune-related adverse events in patients with advanced cutaneous melanoma treated with immune checkpoint inhibitors.

AU - Gandhi, Aesha

AU - Taylor, John

AU - Morici, Michael

AU - Reid, Anna

AU - Meniawy, Tarek

AU - Khattak, Muhammad Adnan

AU - Gray, Elin

AU - Millward, Michael

AU - Zaenker, Pauline

PY - 2022/6/1

Y1 - 2022/6/1

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000863680302355?SID=EUW1ED0F8DJeyy75FF4UMJDlSowp0

M3 - Abstract/Meeting Abstract

SN - 0732-183X

VL - 40

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 16

ER -

Autoantibodies as potential biomarkers of immune-related adverse events in patients with advanced cutaneous melanoma treated with immune checkpoint inhibitors.

Other files and links

Cite this